Boston, MANCT06815991Now EnrollingIRB Ready

Healthy Adults Clinical Trial in Boston, MA

Access cutting-edge healthy adults treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Metro International Biotech, LLC

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access healthy adults specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related healthy adults treatment provided free

Apply for This Boston Location

Check if you qualify for this healthy adults clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Healthy Adults Study in Boston

This is a single center, open label (i.e. participants and study staff will not be masked to the intervention) single ascending dose study to evaluate the safety, tolerability, pharmaokinetics and pharmacodynamics of MIB-725 in community dwelling, healthy adults. Up to 4 successive groups (cohorts) of 8 subjects each will be enrolled in this trial. This study will determine the safety and tolerability of orally administered single ascending (increasing) doses (100, 200, 400, and 800 mg) of MIB-725 in healthy adults. The safety will be assessed by evaluating physical examination that includes an external eye examination, vital signs, adverse events, and changes in blood counts, EKG, urinalysis, coagulation measures, and blood chemistries, including but not limited to blood glucose, electrolytes, creatinine, liver function tests, uric acid, and creatine kinase.

Sponsor: Metro International Biotech, LLC

Who Can Participate

Inclusion Criteria

Is a non-smoking healthy adult, 19 to 60 years of age, inclusive
Has a body mass index (BMI) between 19 and 37.5 kg/m2, inclusive
Is free from clinically significant medical problems as determined by the Investigator
Is able and willing to provide written informed consent.
Is able and willing to provide authorization for the use and disclosure of personal health information in accordance with the Health Insurance Portability and Accountability Act (HIPAA).

Exclusion Criteria

Is a current cigarette smoker
AST or ALT \> 1.5 times the upper limit of normal
Hematocrit \< 37% or \> 51%
Diagnosis of diabetes mellitus, as indicated by use of diabetes medication, hemoglobin A1C \> 6.4% or fasting glucose ≥126 mg/dL
Serum creatinine \> 2.0 mg/dL
Current use of barbiturates, benzodiazepines, opiates, amphetamine, cannabinoids and cocaine
Known allergy to niacin or nicotinamide mononucleotide
Unwilling to refrain from drinking alcohol during the duration of the study
Use of any other dietary supplement during the course of the trial
Use of anabolic steroids, rhGH, DHEA, androstenedione, or any other performance enhancing drug
In the judgment of the study physician, the participant is unlikely to comply with the study protocol for any reason or it may not be safe to administer the study medication
Has a history of myocardial infarction, stroke, or heart failure in the preceding 6 months.
Has a history of cancer other than nonmelanotic skin cancer requiring treatment in the previous 2 years.
Has other medical conditions which, in the opinion of the Principal Investigator, would jeopardize the safety of the study subject or impact the validity of the study results. In addition, female participants must:
Be postmenopausal as indicated by cessation of menstruation at least one year before screening
Not be pregnant and not planning to become pregnant over the next 6 months Prohibited medications and substances:
Current use of barbiturates, benzodiazepines, opiates, amphetamine, cannabinoids and cocaine
Use of any other dietary supplement during the course of the trial. Subjects who are using a supplement containing nicotinamide, niacin, nicotinamide mononucleotide, or nicotinamide riboside may be included if they agree to stop the supplement at least 2 weeks prior to day 0 and during the entire duration of the study.
Initiation of a new prescription drug during the preceding 4 weeks or during the course of the study
Use of anabolic steroids, rhGH, DHEA, androstenedione, or any other performance enhancing drug \-

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06815991) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Healthy Adults Treatment Options in Boston, MA

If you're searching for healthy adults treatment options in Boston, MA, this clinical trial (NCT06815991) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced healthy adults specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all healthy adults clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Boston, MA

See all alzheimers disease clinical trials recruiting in Boston — not just this study.

Browse Alzheimers Disease Trials in Boston

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA